Morgan Stanley raised its price objective for Iridium, while Raymond James Financial restated its market perform rating, with MarketBeat providing consensus data.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley raised its price objective for Iridium, while Raymond James Financial restated its market perform rating, with MarketBeat providing consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
iridium
chemical element with symbol Ir and atomic number 77
-
Morgan Stanley
U.S. investment bank
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- MarketBeat aggregated analyst ratings for SM Energy, noting an upgrade from Truist Financial and a rating change from Raymond James Financial.
- MarketBeat aggregates data on Salesforce performance, while Raymond James Financial provides analyst ratings for the company.
- Morgan Stanley and Citigroup raised price targets on Appian Corporation, with MarketBeat aggregating the consensus data.
- MarketBeat is aggregating consensus rating data for BrightView stock, and Morgan Stanley has begun investment banking analysis on the company.
- Analyst firms RBC and Morgan Stanley set price targets for OTIS, with MarketBeat aggregating the ratings.